Table: Kaken Pharmaceutical - 9-MTH group results

KAKEN PHARMACEUTICAL

06/02/2024 04:30

Feb 6 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2023        Dec 31, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             54.69               55.57            73.10    
                 (-1.6 pct)          (-3.7 pct)       (+0.2 pct)  
  Operating          8.87               12.39             7.60    
                 (-28.4 pct)         (-10.8 pct)      (-5.0 pct)  
  Recurring          9.30               12.98             8.00    
                 (-28.3 pct)         (-9.4 pct)       (-8.3 pct)  
  Net                6.68                9.15             6.70    
                 (-27.0 pct)         (-10.7 pct)      (+23.2 pct) 
  EPS            177.10 yen          243.31 yen       176.92 yen  
  Ann Div                            150.00 yen       150.00 yen  
  -Q2 div         75.00 yen           75.00 yen                   
  -Q4 div                             75.00 yen        75.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T